WhaleQuant.io
Teva Pharmaceutical Industries Limited (TEVA) Corporate Logo

Teva Pharmaceutical Industries Limited (TEVA) Stock Price & Analysis

Market: NYSE • Sector: Healthcare • Industry: Drug Manufacturers - Specialty & Generic

Teva Pharmaceutical Industries Limited (TEVA) Profile & Business Summary

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Key Information

Ticker TEVA
Exchange NYSE
Official Site https://www.tevapharm.com
CIK Number 0000818686
View SEC Filings

Market Trend Overview for TEVA

One model, two time views: what the market looks like right now, and where the larger trend is heading over time.

Longer-Term Market Trend (Mid to Long Term)

Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-11-17 (ET)

As of 2026-11-17, TEVA is moving sideways without a clear direction. Over the longer term, the trend remains bullish.

TEVA last closed at 42.62. The price is about 0.9 ATR above its recent average price (41.64), and the market is currently in a sideways market without a clear direction. Price at 42.62 is moving between minor support near 40.92 and minor resistance near 43.34. Direction remains unclear. View Support & Resistance from Options

The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.

Trend Alignment Summary

Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.

Key Risk Level

A key downside risk boundary is near 38.20. If price falls below this area, the current structure would likely weaken further.

Recent Trend Signal

A systematic trend-activation signal was most recently triggered on 2026-11-10, reflecting a technical shift toward positive directional alignment.

Recent Price Behavior

Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.

Overnight Positioning

There was no clear sign of meaningful positions being carried into the overnight session.

Next-day directional probability forecast Last updated: 2026-11-17 (ET)
Next-session outlook for 2026-11-18 (ET)
No clear next-day edge

What the model sees

The model stays neutral because the setup is not clear enough to justify a directional deployment.


Why the model says this

The model does not deploy this setup because predictability is still too low. Predictability is 36%, agreement is 86%, and reversal risk is 16%.

NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history

Recent Cost Distribution Last updated: 2026-11-17 (ET)

This estimate uses 1-minute price, volume, and VWAP data from the last 55 trading days, with turnover-based decay. The sample period is 2026-09-01 to 2026-11-17. The current price is 42.62, 3.91% above the estimated average cost of 41.02. An estimated 83.9% of recent positioning is below the current price, while 15.9% is above it. The peak-density price is 41.22. The largest concentrated cost region is 40.99 to 42.37 and contains 39.1% of the estimated distribution. The nearest region below the current price is 42.41 to 42.53. The nearest region above the current price is 42.63 to 42.69.

Short Interest & Covering Risk for TEVA

This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.

Squeeze Score 0.52

Shows how likely a short squeeze may be under current market conditions.

Key Market Risk Indicators
Short Crowding (Short Interest / Float) 2.50%
Short Positions Trend Not Increasing
Liquidity Trend (Average Daily Volume) -2.73%
20-Day Return 4.33%
Price vs 20-Day High Below Recent Highs

Short Exposure Percentile

Short interest is within its typical range, with no clear imbalance between buyers and sellers. (Historical percentile: 51%)

Structure Analysis

TEVA Short positioning is starting to look crowded. Current days to cover is 5.3 trading days, meaning short positions would unwind somewhat slower than average. Short covering could add extra momentum to price moves. No meaningful structural fragility is currently detected (Fragility Score 0/100, DTC percentile 89%). Positioning is historically elevated, although price and liquidity conditions do not yet confirm structural fragility.

Risk Summary

No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.

Why Price Reactions May Be Stronger?

Days-to-Cover is elevated versus its own history, but absolute short interest remains moderate. Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 2× larger than usual.


Note: Short interest data is reported every two weeks by FINRA. The most recent snapshot is 2026-10-30 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.

Analytical Modules